AlloSource: Research shows ProChondrix maintains high cell viability

AlloSource: Research shows ProChondrix maintains high cell viability

CENTENNIAL -- AlloSource announced research results showing ProChondrix CR maintains consistent, high cell viability for two years when stored at -80̊ C. Allosource said the research found... Read More

Tuesday October 8, 2019 0 comments Tags: Centennial, AlloSource, ProChondrix CR, Peter Stevens

AlloSource announces first patient enrolled in cartilage defect study

AlloSource announces first patient enrolled in cartilage defect study

CENTENNIAL -- AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, announced it enrolled the first patient in a study titled A... Read More

Thursday March 21, 2019 0 comments Tags: Centennial, AlloSource, ProChondrix CR, Ross Wilkins

AlloSource granted patent for proprietary tissue laser cutting enclosure

AlloSource granted patent for proprietary tissue laser cutting enclosure

CENTENNIAL -- AlloSource announced it received U.S. patent 10,105,793, titled Enclosure for laser cutting of human tissue . This patent encompasses AlloSource's method of producing a closed... Read More

Monday November 19, 2018 0 comments Tags: Centennial, AlloSource, ProChondrix CR, Ross Wilkins

AlloSource, Stryker announce launch of ProChondrix CR allograft for cartilage repair

AlloSource, Stryker announce launch of ProChondrix CR allograft for cartilage repair

CENTENNIAL -- AlloSource and Stryker jointly announced the launch of ProChondrix CR, a single-stage, natural solution for patients in need of articular cartilage repair. AlloSource said... Read More

Monday April 9, 2018 0 comments Tags: Centennial, AlloSource, Stryker, ProChondrix CR, Kerr Holbrook